#StopBigPharma
The Lawsuit to Stop the Conspiracy
PharmacyChecker is suing Big Pharma-allied groups to protect consumers’ access to information about more affordable medicine from safe international online pharmacies.
Court Filings
- Complaint of Conspiracy: PharmacyChecker.com LLC v. National Association of Boards of Pharmacy et al (nysd-7:2019-cv-07577)
- Amended Complaint of Conspiracy: PharmacyChecker.com LLC v. National Association of Boards of Pharmacy et al (Civil Action No. 7:19-cv-07577-KMK)
This is a case about a company, PharmacyChecker.com, that, for over 20 years, has provided pharmacy verification services and information that helps consumers identify online pharmacies that sell genuine, safe and affordable prescription medication to treat conditions such as high blood pressure, asthma, and diabetes. For much of that time, Big Pharma has funded organizations and campaigns that misinform the public about online pharmacies, importation, and drug prices. They have sought to discredit PharmacyChecker’s mission to help patients struggling with high prescription drug costs. The case, which has been filed in New York and Oregon against multiple defendants, alleges an unlawful conspiracy to suppress the information that PharmacyChecker provides to the public.
Case Updates Updated May 27, 2025
We are pleased to report that on May 23, 2025, the United States Court of Appeals for the Ninth Circuit unanimously affirmed that PharmacyChecker has standing to pursue its antitrust case against LegitScript. The ruling recognizes that PharmacyChecker operates a legal business that provides critical information for consumers, caretakers, and clinicians to compare prescription drug prices and locate safe, accredited pharmacies internationally. During the long course of this case, PharmacyChecker has been recognized in the Journal of the American Medical Association as a valuable resource "to find a reputable online pharmacy that can supply high-quality prescription drugs." The court rejected LegitScript’s argument that falsely characterized our work as unlawful and tried to use that mischaracterization to avoid accountability under antitrust law.
In New York, we also continue to pursue our case against NABP under the Lanham Act, after U.S. District Judge Kenneth M. Karas denied NABP’s motion to dismiss that claim in March 2024.
PharmacyChecker looks forward to continuing its fight for competition and transparency in prescription drug pricing.
Tell Google and Bing to Stop Suppressing Lower Drug Price Options
